佐力藥業(300181.SZ)終止非公開發行股票事項
格隆匯9月28日丨佐力藥業(300181.SZ)公佈,近日,公司收到浙醫健關於解除《非公開發行股票認購協議》通知,具體內容如下:浙醫健自與公司簽署《非公開發行股票認購協議》後,一直積極推進協議收購及認購公司股份事項的審批工作。近日,浙醫健收到控股股東浙江省旅遊集團有限責任公司轉來的《浙江省國資委關於浙江省醫療健康集團有限公司收購浙江佐力藥業股份有限公司事項的意見》,浙江省國資委認為浙醫健暫不具備收購公司的條件,未予批准協議收購及認購公司股份事項。鑑於浙江省國資委審核未通過,且公司股東俞有強與浙醫健簽署的《股份轉讓協議》因未達成生效條件而自動解除,浙醫健與公司簽署的《非公開發行股票認購協議》亦自動解除。
公司於2020年9月28日召開了第六屆董事會第三十一次(臨時)會議、第六屆監事會第二十八次(臨時)會議,分別審議通過了《關於終止非公開發行股票事項的議案》,同意公司終止非公開發行股票事項。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.